China Traditional Chinese... (CHIZF)
China Traditional Chinese Medicine Statistics
Share Statistics
China Traditional Chinese Medicine has 5.04B shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 5.04B |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 11.96 and the forward PE ratio is null. China Traditional Chinese Medicine's PEG ratio is 0.16.
| PE Ratio | 11.96 |
| Forward PE | n/a |
| PS Ratio | 0.85 |
| Forward PS | n/a |
| PB Ratio | 0.73 |
| P/FCF Ratio | 22.59 |
| PEG Ratio | 0.16 |
Enterprise Valuation
China Traditional Chinese Medicine has an Enterprise Value (EV) of 17.51B.
| EV / Sales | 0.97 |
| EV / EBITDA | 6.85 |
| EV / EBIT | 14.98 |
| EV / FCF | 25.74 |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.24.
| Current Ratio | 2.12 |
| Quick Ratio | 1.48 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 2.02 |
| Debt / FCF | 7.59 |
| Interest Coverage | 7.17 |
Financial Efficiency
Return on Equity is 6.07% and Return on Invested Capital is 5.3%.
| Return on Equity | 6.07% |
| Return on Assets | 3.47% |
| Return on Invested Capital | 5.3% |
| Revenue Per Employee | $1,081,708.41 |
| Profits Per Employee | $76,714.62 |
| Employee Count | 16,753 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.48 |
Taxes
| Income Tax | -171.54M |
| Effective Tax Rate | -14.01% |
Stock Price Statistics
The stock price has increased by -28.77% in the last 52 weeks. The beta is 0.78, so China Traditional Chinese Medicine's price volatility has been higher than the market average.
| Beta | 0.78 |
| 52-Week Price Change | -28.77% |
| 50-Day Moving Average | 0.34 |
| 200-Day Moving Average | 0.37 |
| Relative Strength Index (RSI) | 0.02 |
| Average Volume (20 Days) | 1,426 |
Income Statement
In the last 12 months, China Traditional Chinese Medicine had revenue of 18.12B and earned 1.29B in profits. Earnings per share was 0.26.
| Revenue | 18.12B |
| Gross Profit | 9.27B |
| Operating Income | 1.43B |
| Net Income | 1.29B |
| EBITDA | 2.56B |
| EBIT | 1.42B |
| Earnings Per Share (EPS) | 0.26 |
Balance Sheet
The company has 3.02B in cash and 5.16B in debt, giving a net cash position of -2.14B.
| Cash & Cash Equivalents | 3.02B |
| Total Debt | 5.16B |
| Net Cash | -2.14B |
| Retained Earnings | 8.54B |
| Total Assets | 37.55B |
| Working Capital | 10.66B |
Cash Flow
In the last 12 months, operating cash flow was 1.17B and capital expenditures -488.61M, giving a free cash flow of 680.2M.
| Operating Cash Flow | 1.17B |
| Capital Expenditures | -488.61M |
| Free Cash Flow | 680.2M |
| FCF Per Share | 0.14 |
Margins
Gross margin is 51.18%, with operating and profit margins of 7.88% and 7.09%.
| Gross Margin | 51.18% |
| Operating Margin | 7.88% |
| Pretax Margin | 6.76% |
| Profit Margin | 7.09% |
| EBITDA Margin | 14.11% |
| EBIT Margin | 7.88% |
| FCF Margin | 3.75% |
Dividends & Yields
CHIZF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 8.36% |
| FCF Yield | 4.43% |
Analyst Forecast
Currently there are no analyst rating for CHIZF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 1.91 |
| Piotroski F-Score | 6 |